These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 372845)

  • 21. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I; Schmidt FW; Müller R; Ranft U; Wildhirt E; Holzer E; Wallnöfer H; Korb G
    Dtsch Med Wochenschr; 1980 Mar; 105(10):330-2. PubMed ID: 6153953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D
    Prog Clin Biol Res; 1986; 213():559-69. PubMed ID: 3520595
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 25. Palmitoyl-catechin for alcoholic liver disease: results of a three-month clinical trial.
    World MJ; Ryle PR; Aps EJ; Shaw GK; Thomson AD
    Alcohol Alcohol; 1987; 22(4):331-40. PubMed ID: 3322310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyanidanol: will a hepatotrophic drug from Europe go west?
    Hepatology; 1983; 3(1):121-3. PubMed ID: 6822375
    [No Abstract]   [Full Text] [Related]  

  • 27. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Am J Gastroenterol; 2005 Nov; 100(11):2583-91. PubMed ID: 16279916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W; Leube G
    Med Klin; 1978 Oct; 73(41):1432-6. PubMed ID: 703670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical analysis of 4 cases of severe viral hepatitis treated with catergen].
    Rzeszowska G; Modrzewska R; Radomińska I
    Wiad Lek; 1980 May; 33(9):739-43. PubMed ID: 7405243
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A; Paál M; Kádas I; Kerekes E; Jávor T
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L; Poznańska H; Rychalska B
    Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S; Halpern Z; Gutman M; Shpirer Z; Baratz M; Bass D
    Gut; 1985 Sep; 26(9):975-9. PubMed ID: 3896964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
    De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
    Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy of alcoholic liver damage].
    Thaler H
    Verh Dtsch Ges Inn Med; 1988; 94():312-6. PubMed ID: 3061201
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antioxidant therapy in chronic liver diseases].
    Lengyel G; Tulassay Z
    Orv Hetil; 2006 Jun; 147(24):1113-8. PubMed ID: 16865855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alcoholic liver diseases and their treatment].
    Cacciatore L; Antoniello S; Russo M
    Clin Ter; 1989 Nov; 131(4):225-32. PubMed ID: 2480864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["Catergen" in the treatment of hepatitis].
    Gładysz A; Juszczyk J
    Wiad Lek; 1985 Jul; 38(14):1039-42. PubMed ID: 3907149
    [No Abstract]   [Full Text] [Related]  

  • 38. Gut-liver axis: a new point of attack to treat chronic liver damage?
    Loguercio C; De Simone T; Federico A; Terracciano F; Tuccillo C; Di Chicco M; Cartenì M
    Am J Gastroenterol; 2002 Aug; 97(8):2144-6. PubMed ID: 12190198
    [No Abstract]   [Full Text] [Related]  

  • 39. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 40. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
    Depew W; Boyer T; Omata M; Redeker A; Reynolds T
    Gastroenterology; 1980 Mar; 78(3):524-9. PubMed ID: 6985881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.